The best price for Wegovy is $25/fill ⚠️ requires insurance coverage
Coverage unlocks $25/fill pricing (via the savings offer)—that's $3,900+/year in savings for the injectable, or $1,500+/year for the pill. Denied? You can appeal, and 65%+ succeed.
Haven't applied for coverage?
Learn what documentation you need and how to improve your approval odds.
See the coverage guide →✓ Free guide · ✓ Step-by-step processDenied Wegovy coverage?
65%+ of appeals succeed with proper documentation.[14] Don't give up.
Get help with your appeal →✓ Free case review · ✓ Could save thousands/yearInsurers Hope You'll Give Up — Don't.
Shopping for Wegovy prices because your insurance denied coverage? You're not alone — nearly half of GLP-1 prescriptions are denied on the first try.[13] But here's what insurers don't tell you: over 65% of appeals succeed when patients fight back.[14]
Before paying $349/month out of pocket, consider appealing — it's free to file and takes about 15 minutes to start. If you win, you could pay as little as $25 a month with the savings offer.
2025-2026 PRICING OVERVIEW
How Much Does Wegovy Cost?
The list price for Wegovy injection is $1,349/month (28-day supply). But what you actually pay depends on your insurance, savings programs, and which form you choose. The new oral pill is significantly cheaper.[1]
Quick Cost Summary (January 2026)
- Injectable list price: $1,349/month (all doses)
- With insurance + savings offer: as little as $25 a month[6]
- NEW Oral Wegovy: $149–$299/mo (launched January 5, 2026)
- Self-pay intro offer: $199/month for the first two fills (0.25 mg and 0.5 mg), through December 31, 2026[9]
Here's the good news: Wegovy is a preferred option on some major formularies. Major pharmacy benefit managers (PBMs) like CVS Caremark list it as a preferred option. With the right insurance and savings programs, your actual cost can be as low as $25/month.
| Payment Scenario | Monthly Cost | Annual Cost |
|---|---|---|
| Injectable list price (no discounts) | $1,349/month | $16,188 |
| Insurance + Savings Offer | $25+ | $300+ |
| NEW: Oral Wegovy (starter) | $149 | $1,788 |
| Self-pay intro offer | $199 | N/A (first 2 fills only, 0.25 mg and 0.5 mg) |
| Self-pay (after intro) | $349 | $4,188 |
Prices verified October 2, 2026. Actual costs may vary by location, pharmacy, and eligibility.
INJECTABLE (WITHOUT INSURANCE)
Wegovy List Price
Without insurance or discounts, Wegovy injection costs $1,349/month (28-day supply)—the same price regardless of dose strength.[1] This is Novo Nordisk's official list price before any discounts are applied.
| Dose | Supply | List Price | Annual Cost |
|---|---|---|---|
| 0.25 mg (starter) | 4 pens | $1,349/month | ~$17,537 |
| 0.5 mg | 4 pens | $1,349/month | ~$17,537 |
| 1 mg | 4 pens | $1,349/month | ~$17,537 |
| 1.7 mg | 4 pens | $1,349/month | ~$17,537 |
| 2.4 mg (maintenance) | 4 pens | $1,349/month | ~$17,537 |
Why the Same Price for All Doses?
Novo Nordisk uses flat pricing across all Wegovy injection doses, meaning your cost doesn't increase as your doctor gradually increases your dose over time. This removes financial barriers to reaching the dose that works best for you.
WHAT YOU'LL ACTUALLY PAY
Wegovy Cost With Insurance
If your insurance covers Wegovy, your out-of-pocket cost depends on three things: your plan's drug list (called a "formulary"), your deductible (the amount you pay before insurance kicks in), and your copay type. You might pay a flat fee (copay) or a percentage of the cost (coinsurance).
Good News: Strong Formulary Placement
Wegovy has favorable formulary placement among GLP-1 weight loss medications (a class of drugs that reduce appetite). CVS Caremark, one of the largest PBMs, has listed Wegovy as preferred since July 2025 (From July 1, 2025 to September 30, 2026, Zepbound was nonpreferred or excluded on CVS Caremark’s most common commercial formularies, with Wegovy preferred; Since October 1, 2026, Zepbound is back on CVS Caremark’s commercial template formularies as an additional preferred option (plan sponsors can customize)). Preferred status can mean better coverage for Wegovy patients whose plans cover weight-loss drugs.[2]
| Insurance Scenario | Typical Monthly Cost | Notes |
|---|---|---|
| Preferred tier + Savings Offer | $25+ | Best case scenario |
| Non-preferred tier + Savings Offer | $25–$150 | Savings covers up to $100 per 1-month fill[6] |
| Covered, no savings offer | $150–$500 | Specialty tier copay/coinsurance |
| Covered after deductible | $1,349/month → then copay | Pay list price until deductible met |
| Not covered / excluded | $1,349/month | Consider oral option or appeal |
Coverage by Major Insurer
Wegovy coverage varies by insurer and plan. Here's a general overview:
- CVS Caremark: Wegovy preferred since July 2025—often better coverage. Since October 1, 2026, Zepbound is back on CVS Caremark’s commercial template formularies as an additional preferred option (plan sponsors can customize)[3]
- Aetna: May cover with prior authorization (pre-approval from your insurer) for obesity
- BCBS: Varies by state and plan—check your specific policy
- Cigna: Coverage varies. Cigna plans may require step therapy; check your plan’s policy
- UnitedHealthcare: Coverage varies by plan
Check Your Coverage First
Before assuming you'll pay list price, verify your plan's formulary and prior authorization requirements. Even if initially denied, over 65% of prior authorization appeals succeed.
Need help navigating insurance coverage? See our insurance coverage guide →
YOUR OPTIONS
Ways to Save on Wegovy
There are several legitimate ways to reduce your Wegovy costs. Here's a quick comparison:
| Savings Option | Monthly Cost | Who Qualifies | Best For |
|---|---|---|---|
| Wegovy Savings Offer | $25+ | Commercial insurance only | Insured patients |
| Oral Wegovy (NEW) | $149–$299/mo | Anyone with prescription | Self-pay or not covered |
| NovoCare PAP | Not available for Wegovy | Wegovy is not on the PAP list | Other Novo medicines (e.g. insulins, Ozempic) |
| NovoCare Self-Pay Intro | $199/month, first 2 fills | New patients (0.25mg & 0.5mg) | Getting started |
Which Option Is Right for You?
You have commercial insurance that covers Wegovy
Use the Wegovy Savings Offer to pay as little as $25 a month. This is the best deal available.
Your insurance doesn't cover Wegovy injection
Consider the new oral Wegovy at $149–$299/month—much cheaper than the $1,349/month injectable list price. Or try the NovoCare self-pay intro: $199/month for the first two fills (0.25 mg and 0.5 mg), through December 31, 2026.
You're uninsured and have limited income
Novo Nordisk PAP is not a route to free Wegovy: Wegovy is not on Novo Nordisk’s Patient Assistance Program list. The lowest-cost self-pay options are the Wegovy pill ($149–$299/month) and the self-pay intro offer. Call NovoCare at 1-888-809-3942 to ask about current options.
You were denied coverage
Appeal the denial—over 65% succeed. While appealing, consider the oral option or self-pay intro to bridge the gap.
If your insurance denied Wegovy or doesn't cover it, you may still have options.
Your GLP-1 coverage,
denied approved
✓ Free Templates✓ Premium Support Available
I was denied coverage for...
Get startedFDA APPROVED DECEMBER 2025
NEW: Oral Wegovy Pricing
Major Cost Breakthrough
The FDA approved oral Wegovy (semaglutide, the active ingredient) on December 22, 2025—the first oral GLP-1 approved for weight loss. The oral form starts at $149/month for the starting dose, making it significantly more affordable than the $1,349/month injection list price.[4]
| Dose | Cash Price | Notes |
|---|---|---|
| 1.5 mg (starter) | $149/month | Starting dose |
| 4 mg | $199/month | Step-up dose |
| 9 mg | $299/month | Escalation dose |
| 25 mg (maintenance) | $299/month | Maintenance dose |
Self-pay pricing per NovoCare.
Oral vs. Injectable: Which Is Better Value?
| Factor | Oral Wegovy | Injectable Wegovy |
|---|---|---|
| Cash price | $149–$299/mo | $1,349/month (list); $349/mo self-pay |
| Weight loss | Up to 16.6%[5] | 14.9%[12] |
| Dosing | Daily pill | Weekly injection |
| Insurance coverage | TBD (new) | Strong PBM placement |
Oral May Actually Work Better
Clinical trials showed oral Wegovy (25mg maintenance) achieved up to 16.6% weight loss vs 14.9% for the injection—while being significantly cheaper without insurance.[5]
Want the full breakdown? See our complete oral Wegovy guide →
FOR INSURED PATIENTS (VIA NOVOCARE)
Wegovy Savings Offer
The Wegovy Savings Offer (through NovoCare) is a manufacturer discount program that can reduce your copay to as little as $25/month if you have commercial insurance.[6]
How It Works
- Maximum savings: Up to $100 per 1-month fill (as of January 2, 2026)
- Your cost: As low as $25/month, reachable when your copay before the offer is $125 or less (higher copays still save up to $100)
- Enrollment: Free at novocare.com; for Savings Offer questions, call 1-888-793-1218
- Terms updated: January 2, 2026 (check NovoCare for current terms)
| Fill | Your Insurance Copay | Savings Offer Covers | You Pay |
|---|---|---|---|
| 1-mo | $25 | $0 | $25 |
| 1-mo | $75 | $50 | $25 |
| 1-mo | $125 | $100 (max) | $25 |
| 1-mo | $200 | $100 (max) | $100 |
| 2-mo | $225 | $200 (max) | $25 |
| 3-mo | $325 | $300 (max) | $25 |
Who Qualifies
- Commercial/private insurance
- Employer-sponsored plans
- ACA marketplace plans
- COBRA coverage
NOT Eligible
Government insurance beneficiaries cannot use the savings offer: Medicare, Medicaid, TRICARE, VA, and similar programs. This is federal law, not Novo Nordisk's policy.
Ready to enroll? Visit novocare.com →
FOR UNINSURED OR LOW-INCOME PATIENTS
Patient Assistance Programs
Novo Nordisk offers a patient assistance program (PAP) for those who qualify, but Wegovy is not on Novo Nordisk’s Patient Assistance Program list.
Novo Nordisk PAP (NovoCare)
The Novo Nordisk Patient Assistance Program covers insulins, Ozempic and other listed products, not Wegovy. For the products it does list, eligibility typically includes:
- Uninsured or on Medicare
- Income-qualified (household income ≤400% of federal poverty level)[11]
- U.S. resident
- Prescription from licensed provider
How to Apply
For Wegovy, call NovoCare at 1-888-809-3942 or visit novocare.com to ask about current savings and self-pay options. For other Novo medicines, the PAP line is 1-866-310-7549; you'll need income verification and a valid prescription.
Other Options for Uninsured Patients
| Option | Monthly Cost | Best For |
|---|---|---|
| Novo Nordisk PAP | Not available for Wegovy | Wegovy is not on the PAP list |
| Oral Wegovy | $149–$299 | Self-pay patients (no income limits) |
| NovoCare Self-Pay Intro | $199/month, first 2 fills | New patients (0.25mg & 0.5mg doses) |
WHAT'S CHANGING
Wegovy Cost Outlook for 2026
Major Pricing Changes in 2026
2026 brought significant changes to Wegovy affordability—including the new oral option, the Medicare GLP-1 Bridge, and TrumpRx.
Confirmed for 2026
Oral Wegovy Launches
The new oral Wegovy pill (FDA approved December 2025) is now available at 70,000+ US pharmacies. Pricing: $149–$299/month depending on dose—a major price breakthrough compared to the $1,349/month injection list price.[4]
Medicare Coverage for Heart Health
Wegovy may be covered under Part D for its heart health benefit (cardiovascular risk reduction) in adults with established cardiovascular disease and either obesity or overweight (FDA-approved for the injection March 8, 2024 (Wegovy injection); tablets December 22, 2025 (Wegovy tablets)), subject to the plan’s formulary, prior authorization and exceptions process; your cost depends on your plan. The SELECT trial showed Wegovy reduces heart attacks and strokes by 20%.[7][10] For weight loss, the Medicare GLP-1 Bridge is live now:
Medicare and weight-loss GLP-1s: the Medicare GLP-1 Bridge
Through the Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), a temporary CMS demonstration that runs outside the Part D benefit, people with eligible Part D coverage can get Wegovy, Foundayo or the Zepbound KwikPen for weight loss for $50 a month, if they meet CMS’s eligibility criteria and their prescriber gets prior authorization.
Source: CMS, Medicare GLP-1 Bridge · Facts in this box verified October 5, 2026
TrumpRx Direct-Purchase Program
Novo Nordisk participates in TrumpRx, which launched February 5, 2026. TrumpRx lists the manufacturers’ own self-pay prices (not a separate, cheaper price): for the Wegovy injection that is NovoCare's self-pay price of $349/month ($399 for Wegovy HD 7.2 mg), used as a coupon at a retail pharmacy.[8]
Pending / TBD
Savings Offer Terms (Updated January 2026)
The Wegovy Savings Offer terms were updated January 2, 2026. Maximum savings are now $100 per 1-month fill, and the lowest cost is $25/month. Check NovoCare for current terms.
Insurance Coverage for Oral
It's unclear how quickly insurers will add oral Wegovy to formularies. Coverage may lag behind the launch.
2026 Cost Projections
| Payment Method | Previous | 2026 Cost |
|---|---|---|
| Oral Wegovy (new) | N/A | $149–$299/mo |
| TrumpRx (injectable) | N/A | Same as NovoCare self-pay ($349/mo) |
| Medicare GLP-1 Bridge (weight loss) | Not covered | $50 per monthly fill (with conditions) |
| Injectable (list price) | $1,349/month | Same |
| Savings Offer (with insurance) | $0–$25/mo | $25+/mo (max savings $100 per 1-month fill) |
What Should You Do Now?
- Using the Savings Offer? Terms updated Jan 2, 2026—now $25+ minimum copay
- Prefer pills over injections? Oral Wegovy is now available at $149–$299/mo
- On Medicare? The Medicare GLP-1 Bridge covers Wegovy for weight loss for $50 per monthly fill (July 1, 2026 – December 31, 2027), if you meet CMS’s criteria and your prescriber gets prior authorization
- Paying cash? Oral Wegovy ($149–$299/mo) or NovoCare self-pay for the injection ($349/mo, the same price TrumpRx lists) cost far less than list price ($1,349/month)
WEGOVY COST FAQS
Frequently Asked Questions
The injectable list price is $1,349/month regardless of dose. With the Wegovy Savings Offer (commercial insurance), you may pay as little as $25/month (as of January 2026). The oral Wegovy pill ranges from $149–$299/month depending on dose.
Wegovy has favorable formulary placement among GLP-1 weight loss medications. Major pharmacy benefit managers like CVS Caremark list Wegovy as preferred (since October 1, 2026, alongside Zepbound)—which can mean better coverage. However, coverage varies by plan, and you may need prior authorization (pre-approval).
For insured patients: Use the Wegovy Savings Offer to pay as low as $25/month. For self-pay patients: The oral Wegovy pill costs $149–$299/month—much cheaper than the $1,349/month injectable list price; NovoCare self-pay for the injection is $349/month ($399 for Wegovy HD 7.2 mg). Note that Wegovy is not on Novo Nordisk’s Patient Assistance Program list, so Novo Nordisk's Patient Assistance Program is not a route to free Wegovy.
No. Government insurance beneficiaries (Medicare, Medicaid, TRICARE, VA) cannot use manufacturer savings offers. This is federal law. However, Wegovy may be covered under Part D for cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight, subject to the plan’s formulary, prior authorization and exceptions process, and the Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027) covers Wegovy for weight loss for $50 per monthly fill if you meet CMS’s eligibility criteria and your prescriber gets prior authorization.
Yes, for cash-pay patients. Oral Wegovy costs $149/month (1.5mg starter dose) to $299/month (25mg maintenance). The injectable is $1,349/month at list price, or $349/month ($399 for Wegovy HD 7.2 mg) through NovoCare self-pay. However, with insurance + savings offer, the injectable may cost as little as $25/month.
Enroll free at novocare.com; for Savings Offer questions, call 1-888-793-1218. You'll receive a card to present at the pharmacy. Must have commercial insurance—government programs excluded. As of January 2026, max savings is $100 per 1-month fill with a $25 minimum copay.
For the injectable, no—all doses cost $1,349/month at list price. For oral Wegovy, pricing increases with dose: $149 (1.5mg starter) → $199 (4mg) → $299 (9mg & 25mg maintenance).
Yes, with conditions, through the Medicare GLP-1 Bridge, a temporary CMS program that runs outside your Part D benefit. Through the Medicare GLP-1 Bridge (July 1, 2026 – December 31, 2027), Medicare Part D enrollees who meet CMS’s eligibility criteria and get prior authorization pay $50 per monthly fill for Wegovy for weight loss. Not eligible if you have type 2 diabetes, moderate-to-severe obstructive sleep apnea, or noncirrhotic MASH with moderate-to-advanced liver fibrosis (F2–F3), or if your Part D plan paid for a GLP-1 for you at any time in 2026. Wegovy also may be covered under Part D for cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight, subject to the plan’s formulary, prior authorization and exceptions process, at your plan’s cost-sharing.
WHERE TO GO FROM HERE
Next Steps
Compare GLP-1 Costs
See how Wegovy pricing compares to other weight loss medications
References
- TrumpRx.gov. "Wegovy." List price. trumprx.gov
- Drug Topics. (July 2025). "CVS Caremark Makes Wegovy Preferred Weight-Loss Medication." drugtopics.com
- CVS Caremark. (2025). "Enabling wider access to effective weight management treatment." business.caremark.com
- Novo Nordisk. (January 2026). "Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America." PRNewswire
- New England Journal of Medicine. (2025). "Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity." OASIS 4 trial: 16.6% mean weight loss with treatment adherence. NEJM
- NovoCare. (January 2026). "Wegovy Savings Offer Program Terms and Conditions." Max savings: $100 per 1-month fill; minimum copay $25. novocare.com
- Lincoff AM, et al. (2023). "Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes." New England Journal of Medicine. SELECT trial: 20% reduction in MACE (HR 0.80, 95% CI 0.72-0.90). NEJM
- The White House. (November 2025). "Fact Sheet: President Donald J. Trump Announces Major Developments in Bringing Most Favored Nation Pricing to American Patients." whitehouse.gov
- Novo Nordisk. (November 17, 2025). "Novo Nordisk Launches Introductory Self-Pay Offer for Wegovy and Ozempic for $199 Per Month." PRNewswire
- KFF. (2024). "A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity." kff.org
- NovoCare. (2026). "Novo Nordisk Patient Assistance Program (PAP)." Eligibility: ≤400% FPL, uninsured or Medicare. novocare.com
- Drugs.com. (2026). "Wegovy for Weight Loss: Uses, Side Effects, Dosage." STEP 1 trial: 14.9% mean weight loss. drugs.com
- eMarketer. (2024). "GLP-1 abandonment rates remain high despite booming demand." Nearly 48% of patients' health plans failed to approve a GLP-1 the first time their doctor prescribed it for weight loss. emarketer.com
- American Medical Association. (2024). "Over 80% of prior auth appeals succeed. Why aren't there more?" ama-assn.org
Last updated October 6, 2026 · Key facts verified October 2, 2026
Disclaimer
The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.
While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.